Does Aspirin Use Influence Exacerbations and Morbidity of Chronic Obstructive Pulmonary Disease?

S. Alam, S. Mahmud, Tasbirul Islam
{"title":"Does Aspirin Use Influence Exacerbations and Morbidity of Chronic Obstructive Pulmonary Disease?","authors":"S. Alam, S. Mahmud, Tasbirul Islam","doi":"10.1097/CPM.0000000000000329","DOIUrl":null,"url":null,"abstract":"M echanical ventilation is used often in the intensive care unit (ICU). The term “weaning” is still used to describe the gradual process of decreasing ventilator support but the spontaneous breathing trial (SBT), an assessment of the patient’s ability to breathe while receiving minimal or no ventilator support (eg, 5 cmH2O pressure support and 5 cmH2O end-expiratory pressure),1 is often the decision point for when to extubate a patient. A “T-piece” trial is literally removing the patient from the ventilator but keeping the endotracheal tube in place with supplemental oxygen, only. This requires the patient to ventilate through the tube, but without any extra pressure support, at all. Although many studies performed have failed to show a significant difference in the success of extubation between T-piece and pressure support ventilation (PSV) trials, it is generally accepted that patients tolerate a shorter SBT trial. In this paper, Subirá and colleagues hypothesized that less demanding SBTs could result in higher rates of successful extubation without increasing reintubation rates. To test their hypothesis, they implemented 2 different weaning strategies: a more demanding 2-hour T-piece trial versus a less demanding SBT using 8 cm H2O with zero positive end-expiratory pressure for 30 minutes. The study was conducted over a 16-month period (January 2016 to April 2017) in 18 Spanish ICUs. The patients were randomized into one of the weaning strategies; however, before randomization, the attending physicians had to decide on the extubation strategy. Extubation strategies included reconnecting the patient to the ventilator for 1 hour after the weaning test before attempting extubation and the administration of nasal intermittent positive pressure ventilation or high-flow nasal cannula after extubation. Patients successfully completing an SBT were extubated, no arterial blood gases were required, and they utilized the Borg Dyspnea Scale to record reported dyspnea at the beginning and end of the SBT. Patients who failed SBT were placed back on the ventilator. During the study period, a total of 2649 patients received mechanical ventilation for at least 24 hours in the participating ICUs. Of the 2649 patients, 1501 fulfilled the inclusion criteria, with 578 patients undergoing randomization to undergo a 2-hour T-piece SBT and 575 patients were randomized to undergo a 30-minute SBT with 8 cmH2O PSV. The study team defined successful extubation as remaining free of mechanical ventilation for 72 hours after extubation, which occurred in 473 patients (82.3%) in the PSV group and 428 patients (74%) in the T-piece group. There was a significant difference between the 2 groups, with a higher successful extubation rate in the PSV group. Reintubation within 72 hours occurred in 59 patients (11.1%) in the PSV group, with a median time of 23 hours, whereas reintubation occurred in 58 patients (11.9%) in the T-piece group, with a median time of 24.5 hours. Reasons for reintubation were not significantly different between the 2 groups, and excessive work of breathing was the most common cause in both groups. Of note, the study team noted that mortality at 90 days was significantly lower in the PSV group (13.2%) compared with the T-piece group (17.3%). Weaning protocols can vary among ICUs, but the main goal is to assess whether the patient can be extubated safely and remain so for the remainder of their hospital course. Among intensivists, the preferences for utilizing a PSV or T-piece approach for the SBT are highly variable. Previous literature has concluded that T-piece SBTs reflect the physiological condition and should be preferentially used.2 In addition, there were anecdotal reports suggesting that patients who tolerate PSV well could develop respiratory failure immediately after extubation.3 In this study, Subirá and colleagues have shown the opposite—patients tolerated the PSV better than T-piece during SBT without significant rates of reintubation or other postextubation complications. The authors do acknowledge the limitations of the study, which include the prophylactic use of nasal intermittent positive pressure ventilation and high-flow nasal cannula after extubation without protocol, instances of extubation outside of the protocol, and that the investigators and attending physicians were not blinded to the treatment randomization group. Even though this study shows promising results with regard to successful extubation with the use of PSV SBTs, the limitations are significant, and further investigation is required before these strategies can be implemented among ICUs in their weaning protocols.","PeriodicalId":10393,"journal":{"name":"Clinical Pulmonary Medicine","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/CPM.0000000000000329","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Pulmonary Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/CPM.0000000000000329","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

M echanical ventilation is used often in the intensive care unit (ICU). The term “weaning” is still used to describe the gradual process of decreasing ventilator support but the spontaneous breathing trial (SBT), an assessment of the patient’s ability to breathe while receiving minimal or no ventilator support (eg, 5 cmH2O pressure support and 5 cmH2O end-expiratory pressure),1 is often the decision point for when to extubate a patient. A “T-piece” trial is literally removing the patient from the ventilator but keeping the endotracheal tube in place with supplemental oxygen, only. This requires the patient to ventilate through the tube, but without any extra pressure support, at all. Although many studies performed have failed to show a significant difference in the success of extubation between T-piece and pressure support ventilation (PSV) trials, it is generally accepted that patients tolerate a shorter SBT trial. In this paper, Subirá and colleagues hypothesized that less demanding SBTs could result in higher rates of successful extubation without increasing reintubation rates. To test their hypothesis, they implemented 2 different weaning strategies: a more demanding 2-hour T-piece trial versus a less demanding SBT using 8 cm H2O with zero positive end-expiratory pressure for 30 minutes. The study was conducted over a 16-month period (January 2016 to April 2017) in 18 Spanish ICUs. The patients were randomized into one of the weaning strategies; however, before randomization, the attending physicians had to decide on the extubation strategy. Extubation strategies included reconnecting the patient to the ventilator for 1 hour after the weaning test before attempting extubation and the administration of nasal intermittent positive pressure ventilation or high-flow nasal cannula after extubation. Patients successfully completing an SBT were extubated, no arterial blood gases were required, and they utilized the Borg Dyspnea Scale to record reported dyspnea at the beginning and end of the SBT. Patients who failed SBT were placed back on the ventilator. During the study period, a total of 2649 patients received mechanical ventilation for at least 24 hours in the participating ICUs. Of the 2649 patients, 1501 fulfilled the inclusion criteria, with 578 patients undergoing randomization to undergo a 2-hour T-piece SBT and 575 patients were randomized to undergo a 30-minute SBT with 8 cmH2O PSV. The study team defined successful extubation as remaining free of mechanical ventilation for 72 hours after extubation, which occurred in 473 patients (82.3%) in the PSV group and 428 patients (74%) in the T-piece group. There was a significant difference between the 2 groups, with a higher successful extubation rate in the PSV group. Reintubation within 72 hours occurred in 59 patients (11.1%) in the PSV group, with a median time of 23 hours, whereas reintubation occurred in 58 patients (11.9%) in the T-piece group, with a median time of 24.5 hours. Reasons for reintubation were not significantly different between the 2 groups, and excessive work of breathing was the most common cause in both groups. Of note, the study team noted that mortality at 90 days was significantly lower in the PSV group (13.2%) compared with the T-piece group (17.3%). Weaning protocols can vary among ICUs, but the main goal is to assess whether the patient can be extubated safely and remain so for the remainder of their hospital course. Among intensivists, the preferences for utilizing a PSV or T-piece approach for the SBT are highly variable. Previous literature has concluded that T-piece SBTs reflect the physiological condition and should be preferentially used.2 In addition, there were anecdotal reports suggesting that patients who tolerate PSV well could develop respiratory failure immediately after extubation.3 In this study, Subirá and colleagues have shown the opposite—patients tolerated the PSV better than T-piece during SBT without significant rates of reintubation or other postextubation complications. The authors do acknowledge the limitations of the study, which include the prophylactic use of nasal intermittent positive pressure ventilation and high-flow nasal cannula after extubation without protocol, instances of extubation outside of the protocol, and that the investigators and attending physicians were not blinded to the treatment randomization group. Even though this study shows promising results with regard to successful extubation with the use of PSV SBTs, the limitations are significant, and further investigation is required before these strategies can be implemented among ICUs in their weaning protocols.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿司匹林的使用是否影响慢性阻塞性肺疾病的恶化和发病率?
重症监护室经常使用机械通气。“断奶”一词仍用于描述呼吸机支持减少的渐进过程,但自主呼吸试验(SBT),即在接受最少或不接受呼吸机支持(如5 cmH2O压力支持和5 cmH2O呼气末压力)的情况下对患者呼吸能力的评估,1通常是患者何时拔管的决定点。一项“T型”试验实际上是将患者从呼吸机上取下,但仅在补充氧气的情况下将气管插管固定到位。这需要患者通过导管通气,但根本没有任何额外的压力支持。尽管进行的许多研究未能显示T型管和压力支持通气(PSV)试验在拔管成功率方面的显著差异,但人们普遍认为,患者可以耐受较短的SBT试验。在这篇论文中,Subirá及其同事假设,在不增加再插管率的情况下,要求较低的SBT可以导致更高的成功拔管率。为了验证他们的假设,他们实施了两种不同的断奶策略:一种要求更高的2小时T型试验,另一种要求较低的SBT,使用8cm H2O,呼气末正压为零,持续30分钟。该研究在18个西班牙重症监护室进行,为期16个月(2016年1月至2017年4月)。患者被随机分为断奶策略之一;然而,在随机化之前,主治医师必须决定拔管策略。拔管策略包括在尝试拔管之前,在断奶测试后将患者重新连接到呼吸机上1小时,以及在拔管后给予鼻腔间歇性正压通气或高流量鼻插管。成功完成SBT的患者拔管,不需要动脉血气,他们使用Borg呼吸困难量表记录SBT开始和结束时报告的呼吸困难。SBT失败的患者重新使用呼吸机。在研究期间,共有2649名患者在参与的ICU接受了至少24小时的机械通气。在2649名患者中,1501名符合入选标准,578名患者随机接受2小时T型片SBT,575名患者被随机接受30分钟8 cmH2O PSV SBT。研究团队将成功拔管定义为拔管后72小时内保持无机械通气,PSV组473名患者(82.3%)和T型片组428名患者(74%)发生了这种情况。两组之间存在显著差异,PSV组拔管成功率较高。PSV组有59名患者(11.1%)在72小时内再次插管,中位时间为23小时,而T型管组有58名患者(11.9%)再次插管,其中位时间为24.5小时。两组患者再次插管的原因没有显著差异,过度呼吸是两组患者最常见的原因。值得注意的是,研究团队指出,PSV组90天时的死亡率(13.2%)明显低于T型片组(17.3%)。不同ICU的断奶方案可能有所不同,但主要目标是评估患者是否可以安全拔管,并在剩余的住院过程中保持安全。在重症监护者中,使用PSV或T型片方法进行SBT的偏好是高度可变的。先前的文献已经得出结论,T型SBT反映了生理状况,应该优先使用。2此外,有传闻报道表明,对PSV耐受良好的患者可能在拔管后立即出现呼吸衰竭。3在本研究中,Subirá及其同事的研究结果正好相反——在SBT期间,患者对PSV的耐受性比T形管更好,没有显著的再插管率或其他拔管后并发症。作者承认这项研究的局限性,包括在没有方案的情况下拔管后预防性使用鼻腔间歇性正压通气和高流量鼻插管,在方案之外拔管的情况,以及研究人员和主治医生没有对随机治疗组视而不见。尽管这项研究显示了使用PSV SBT成功拔管的有希望的结果,但其局限性是显著的,在ICU在断奶方案中实施这些策略之前,还需要进一步的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Pulmonary Medicine
Clinical Pulmonary Medicine Medicine-Critical Care and Intensive Care Medicine
自引率
0.00%
发文量
0
期刊介绍: Clinical Pulmonary Medicine provides a forum for the discussion of important new knowledge in the field of pulmonary medicine that is of interest and relevance to the practitioner. This goal is achieved through mini-reviews on focused sub-specialty topics in areas covered within the journal. These areas include: Obstructive Airways Disease; Respiratory Infections; Interstitial, Inflammatory, and Occupational Diseases; Clinical Practice Management; Critical Care/Respiratory Care; Colleagues in Respiratory Medicine; and Topics in Respiratory Medicine.
期刊最新文献
Systemic sclerosis associated myopathy: how to treat. Axillary lymphadenopathy in a high-risk breast screening patient following the COVID-19 vaccine: a diagnostic conundrum. Is a Trial of Observation Safer Than Intervention With Spontaneous Pneumothorax? The Complex Relationship Between Poor Sleep Quality and Chronic Obstructive Pulmonary Disease The Diagnosis of Hypersensitivity Pneumonitis and the Role of Lung Biopsy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1